Bioactive Hydrogel Scaffolds for Controllable Vascular Differentiation of Human Embryonic Stem Cells.
From: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Biomaterials
- Publish Date: Jun 2007
- ISSN: 0142-9612
- Volume: 28
- Issue: 17
- Pages: 2706-17
- Medium: Print
- Language: English
- Citation (JAMA): Ferreira Lino S, Gerecht Sharon, Fuller Jason, et al. Bioactive Hydrogel Scaffolds for Controllable Vascular Differentiation of Human Embryonic Stem Cells.. Biomaterials Jun 2007;28:2706-17
Abstract
We propose a new methodology to enhance the vascular differentiation of human embryonic stem cells (hESCs) by encapsulation in a bioactive hydrogel. hESCs were encapsulated in a dextran-based hydrogel with or without immobilized regulatory factors: a tethered RGD peptide and microencapsulated VEGF(165). The fraction of cells expressing vascular endothelial growth factor (VEGF) receptor KDR/Flk-1, a vascular marker, increased up to 20-fold, as compared to spontaneously differentiated embryoid bodies (EBs). The percentage of encapsulated cells in hydrogels with regulatory factors expressing ectodermal markers including nestin or endodermal markers including alpha-fetoprotein decreased 2- or 3-fold, respectively, as compared to EBs. When the cells were removed from these networks and cultured in media conditions conducive for further vascular differentiation, the number of vascular cells was higher than the number obtained through EBs, using the same media conditions. Functionalized dextran-based hydrogels could thus enable derivation of vascular cells in large quantities, particularly endothelial cells, for potential application in tissue engineering and regenerative medicine.
Mesh Headings (Keywords): Biological Markers, Blood Vessels, Cell Differentiation, Cell Survival, Cells, Cultured, Dextrans, Embryonic Stem Cells, Endothelium, Vascular, Germ Layers, Glycolates, Humans, Hydrogel, Hypoxia-Inducible Factor 1, Kinetics, Microspheres, Protein Transport, Up-Regulation, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-2
Check for Full Text / PubMed Unique Identifier (PMID): 17346788
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.